Read more

June 21, 2024
1 min read
Save

ASTRO names new chief executive officer

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Vivek S. Kavadi, MD, MBA, FASTRO, has been named the new CEO for the American Society for Radiation Oncology.

Kavadi is an ASTRO fellow and currently serves on the society’s board of directors as vice chair of its Health Policy Council. He will take over as the new CEO on Nov. 1 and replaces retiring chief executive Laura Thevenot, who has served as the organization’s chief executive since 2002.

Quote from Vivek S. Kavadi, MD, MBA, FASTRO

A member of ASTRO since 1994, Kavadi is a radiation oncologist with a focus on breast and prostate cancers. He is currently the chief radiation oncology officer for The US Oncology Network. Kavadi has maintained a clinical practice at Texas Oncology since 1995, where he previously served as regional medical director the community-based provider.

"I am deeply honored to step into the CEO role at ASTRO to help advance our wonderful specialty,” Kavadi said in a press release.

“I do not take the challenge of leaving my current role in community cancer care to lead a national organization lightly. I recognize that I will step into the role succeeding Laura Thevenot, who has led the organization with skill and distinction for the past 22 years,” he added. “I know I will be at the helm of a healthy, thriving organization, and I am committed to fostering further collaboration, scientific advancement and excellence within our specialty."

Kavadi received his medical degree from Harvard School of Medicine and also holds an MBA from The Wharton School, University of Pennsylvania. He completed his radiation oncology training at The University of Texas MD Anderson Cancer Center, where he served as chief resident and a faculty member.

“We are so pleased to have Vivek lead ASTRO at this key time for the specialty,” Jeff M. Michalski, MD, MBA, FASTRO, chair of the ASTRO Board of Directors, said in the release. “The appointment of a physician from our specialty with first-hand experience of the challenges that practicing physicians face each day marks an important milestone for ASTRO. Vivek’s deep understanding of the field, as well as his operational and business acumen, makes him an ideal fit for our society.”